Kerstin Pohl

742 total citations
20 papers, 588 citations indexed

About

Kerstin Pohl is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Kerstin Pohl has authored 20 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Kerstin Pohl's work include Cystic Fibrosis Research Advances (10 papers), Neonatal Respiratory Health Research (9 papers) and Inhalation and Respiratory Drug Delivery (4 papers). Kerstin Pohl is often cited by papers focused on Cystic Fibrosis Research Advances (10 papers), Neonatal Respiratory Health Research (9 papers) and Inhalation and Respiratory Drug Delivery (4 papers). Kerstin Pohl collaborates with scholars based in Ireland, United States and Japan. Kerstin Pohl's co-authors include Emer P. Reeves, Noel G. McElvaney, Elaine Hayes, Kevin Molloy, Oliver J. McElvaney, Cormac McCarthy, David A. Bergin, Thomas Efferth, Michelle M. White and Maria P. Morgan and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Kerstin Pohl

19 papers receiving 575 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kerstin Pohl Ireland 13 302 177 127 77 65 20 588
K Krätzel Germany 6 114 0.4× 181 1.0× 176 1.4× 40 0.5× 36 0.6× 6 447
Dania Zhivaki France 9 92 0.3× 375 2.1× 232 1.8× 94 1.2× 68 1.0× 10 633
Noriko Nagi‐Miura Japan 14 234 0.8× 189 1.1× 148 1.2× 63 0.8× 41 0.6× 37 659
Ansen B.P. Burr United States 8 85 0.3× 153 0.9× 229 1.8× 81 1.1× 138 2.1× 10 555
S. Gullini Italy 18 282 0.9× 240 1.4× 234 1.8× 121 1.6× 175 2.7× 47 1.2k
Liviu A. Sicinschi United States 15 224 0.7× 421 2.4× 186 1.5× 96 1.2× 99 1.5× 22 1.0k
Lingadakai Ramachandra India 15 82 0.3× 206 1.2× 214 1.7× 79 1.0× 37 0.6× 30 717
Sally M. Lansley Australia 11 254 0.8× 58 0.3× 66 0.5× 38 0.5× 64 1.0× 18 509
Laura Visconti Italy 9 54 0.2× 99 0.6× 176 1.4× 110 1.4× 86 1.3× 10 462
Ting Song China 13 106 0.4× 195 1.1× 210 1.7× 232 3.0× 63 1.0× 29 732

Countries citing papers authored by Kerstin Pohl

Since Specialization
Citations

This map shows the geographic impact of Kerstin Pohl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerstin Pohl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerstin Pohl more than expected).

Fields of papers citing papers by Kerstin Pohl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerstin Pohl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerstin Pohl. The network helps show where Kerstin Pohl may publish in the future.

Co-authorship network of co-authors of Kerstin Pohl

This figure shows the co-authorship network connecting the top 25 collaborators of Kerstin Pohl. A scholar is included among the top collaborators of Kerstin Pohl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerstin Pohl. Kerstin Pohl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pohl, Kerstin, et al.. (2024). The vacuolar anti-Pseudomonal activity of neutrophil primary granule peptidyl-arginine deiminase enzymes. Frontiers in Immunology. 15. 1452393–1452393. 1 indexed citations
2.
Pohl, Kerstin. (2022). Ensuring the Purity of Gene Therapy Products and Vaccines. Genetic Engineering & Biotechnology News. 42(12). 27–29.
3.
Hayes, Elaine, Mark P. Murphy, Kerstin Pohl, et al.. (2020). Altered Degranulation and pH of Neutrophil Phagosomes Impacts Antimicrobial Efficiency in Cystic Fibrosis. Frontiers in Immunology. 11. 600033–600033. 17 indexed citations
4.
Pohl, Kerstin, Silvia M. Caceres, Katie R. Poch, et al.. (2020). Mycobacterium abscessus Clearance by Neutrophils Is Independent of Autophagy. Infection and Immunity. 88(8). 17 indexed citations
5.
Pohl, Kerstin, David P. Nichols, Jennifer L. Taylor‐Cousar, et al.. (2018). Corticosteroid use and increased CXCR2 levels on leukocytes are associated with lumacaftor/ivacaftor discontinuation in cystic fibrosis patients homozygous for the F508del CFTR mutation. PLoS ONE. 13(12). e0209026–e0209026. 7 indexed citations
6.
Malcolm, Kenneth C., Silvia M. Caceres, Kerstin Pohl, et al.. (2018). Neutrophil killing of Mycobacterium abscessus by intra- and extracellular mechanisms. PLoS ONE. 13(4). e0196120–e0196120. 27 indexed citations
7.
Nick, Jerry A., Kerstin Pohl, & Stacey L. Martiniano. (2016). Nontuberculous mycobacterial infections in cystic fibrosis. Current Opinion in Pulmonary Medicine. 22(6). 629–636. 4 indexed citations
8.
Reeves, Emer P., Cormac McCarthy, Oliver J. McElvaney, et al.. (2015). Inhaled hypertonic saline for cystic fibrosis: Reviewing the potential evidence for modulation of neutrophil signalling and function. World Journal of Critical Care Medicine. 4(3). 179–179. 16 indexed citations
9.
Jundi, Bakr, Kerstin Pohl, Noel G. McElvaney, & Emer P. Reeves. (2015). The importance of CFTR expression for neutrophil function in patients with Cystic Fibrosis. BMC Proceedings. 9(S1). 3 indexed citations
10.
McElvaney, Oliver J., Niamh O’Reilly, Michelle M. White, et al.. (2014). The effect of the decoy molecule PA401 on CXCL8 levels in bronchoalveolar lavage fluid of patients with cystic fibrosis. Molecular Immunology. 63(2). 550–558. 12 indexed citations
11.
Bergin, David A., Oliver J. McElvaney, Cormac McCarthy, et al.. (2014). Galectin-9 Signaling through TIM-3 Is Involved in Neutrophil-Mediated Gram-Negative Bacterial Killing: An Effect Abrogated within the Cystic Fibrosis Lung. The Journal of Immunology. 192(5). 2418–2431. 40 indexed citations
12.
Pohl, Kerstin, Elaine Hayes, Joanne Keenan, et al.. (2014). A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy. Blood. 124(7). 999–1009. 132 indexed citations
13.
14.
15.
Pohl, Kerstin, et al.. (2012). WS9.9 The CFTR potentiator ivacaftor corrects defective degranulation of secondary and tertiary granules by cystic fibrosis neutrophils. Journal of Cystic Fibrosis. 11. S21–S21. 1 indexed citations
16.
Reeves, Emer P., Kevin Molloy, Kerstin Pohl, & Noel G. McElvaney. (2012). Hypertonic Saline in Treatment of Pulmonary Disease in Cystic Fibrosis. The Scientific World JOURNAL. 2012. 1–11. 54 indexed citations
17.
Hurley, Killian, et al.. (2012). Endoplasmic reticulum stress in circulating cystic fibrosis neutrophils. 40. 1446. 1 indexed citations
18.
Hayes, Elaine, Kerstin Pohl, Noel G. McElvaney, & Emer P. Reeves. (2011). The Cystic Fibrosis Neutrophil: A Specialized Yet Potentially Defective Cell. Archivum Immunologiae et Therapiae Experimentalis. 59(2). 97–112. 75 indexed citations
19.
Wafula, Paul O., Ana Teles, Anne Schumacher, et al.. (2009). ORIGINAL ARTICLE: PD‐1 but not CTLA‐4 Blockage Abrogates the Protective Effect of Regulatory T Cells in a Pregnancy Murine Model. American Journal of Reproductive Immunology. 62(5). 283–292. 63 indexed citations
20.
Pohl, Kerstin, et al.. (2008). Molecular Mechanisms Underlying St. Johns Wort Drug Interactions. Current Drug Metabolism. 9(10). 1027–1037. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K Krätzel Breakdown of academic impact, for papers by Dania Zhivaki Breakdown of academic impact, for papers by Noriko Nagi‐Miura Breakdown of academic impact, for papers by Ansen B.P. Burr Breakdown of academic impact, for papers by S. Gullini Breakdown of academic impact, for papers by Liviu A. Sicinschi Breakdown of academic impact, for papers by Lingadakai Ramachandra Breakdown of academic impact, for papers by Sally M. Lansley Breakdown of academic impact, for papers by Laura Visconti Breakdown of academic impact, for papers by Ting Song
Rankless by CCL
2026